Health Care & Life Sciences » Pharmaceuticals | Lee's Pharmaceutical Holdings Ltd.

Lee's Pharmaceutical Holdings Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
176,090.00
228,153.00
253,935.00
282,604.00
257,628.00
446,384
Depreciation, Depletion & Amortization
16,503.00
28,887.00
44,183.00
45,728.00
58,108.00
65,077
Other Funds
2,164.00
3,401.00
37,598.00
48,880.00
22,497.00
228,946
Funds from Operations
194,757.00
260,441.00
260,520.00
377,212.00
293,239.00
282,515
Changes in Working Capital
12,774.00
37,279.00
96,454.00
45,614.00
80,175.00
65,654
Net Operating Cash Flow
181,983.00
223,162.00
164,066.00
422,826.00
373,414.00
348,169
Capital Expenditures
222,056.00
126,802.00
234,430.00
269,670.00
267,472.00
Sale of Fixed Assets & Businesses
51.00
3,590.00
1,954.00
2,978.00
1,704.00
Purchase/Sale of Investments
12,854.00
29,792.00
71,679.00
37,685.00
90,703.00
Net Investing Cash Flow
148,643.00
150,232.00
533,850.00
367,092.00
248,015.00
Cash Dividends Paid - Total
33,238.00
42,938.00
56,173.00
63,108.00
66,727.00
Issuance/Reduction of Debt, Net
37,253.00
17,349.00
15,579.00
68,109.00
8,484.00
Net Financing Cash Flow
8,588.00
52,565.00
362,972.00
7,422.00
72,219.00
Net Change in Cash
45,160.00
13,850.00
55,783.00
37,477.00
49,412.00
Free Cash Flow
36,117.00
155,283.00
58,666.00
283,776.00
236,250.00
Net Assets from Acquisitions
-
30.00
-
-
3,137.00
Other Sources
102,216.00
2,802.00
-
37,275.00
111,593.00
Change in Capital Stock
4,573.00
7,722.00
403,566.00
2,421.00
2,992.00
Exchange Rate Effect
3,232.00
6,515.00
48,971.00
25,679.00
3,768.00
Other Uses
16,000.00
-
229,695.00
99,990.00
-

About Lee's Pharmaceutical Holdings

View Profile
Address
1/F, Building 20 East
Hong Kong
Hong Kong
Employees -
Website http://www.leespharm.com
Updated 07/08/2019
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. It operates through the Proprietary Products and Licensed-in Products segments. The Proprietary Products segment involves in manufacturing and selling self-development pharmaceutical products.